BioSpace News Archive

The Menarini Group, a privately held Italian pharmaceutical and diagnostics company, announced today that the European Commission (EC) has granted a marketing authorization, for ELZONRIS (tagraxofusp) as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare

Echosens , a high-technology company offering the FibroScan family of products, announces its collaborative relationship with Healthy Trucking of America (HTA), the leading authority on health and wellness issues for America’s truckers. The goal of the collaboration is to proactively address liver health among its 770,000 active fleets in the United States, including independent owner/operators and fleet drivers repres

As the resurgence of COVID-19 activity continues in Canada, we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Society for Science (the Society) today named 40 finalists in the Regeneron Science Talent Search 2021, the nation’s oldest and most prestigious science and math competition for high school seniors.

Kaiser Permanente improves colorectal cancer screening rates by offering members the ability to order their own at-home screening tests.

In dire present times, with the threat of COVID-19 looming over, automated immunoassay analyzers market, one of the many sub-spheres of the global healthcare space, has been gaining a lot of prominence. Immunoassay analyzers generally use antibodies as reagents to identify the number of certain substances in a sample – this is particularly why they have been garnering a lot of traction during the COVID-19 phase.

The COVID-19 lockdowns have created substantial disruptions in supply chains in the global animal drugs market, creating challenges for regulators to streamline animal drug flow across their states.

Premier Inc. (NASDAQ: PINC), through its ProvideGx® program, has partnered with Pfizer Inc. to supply five essential medications to healthcare providers, helping to meet the immediate and long-term supply needs of medications necessary to a range of patient care interventions, including some that have been critical during the COVID-19 pandemic.

Powered by A.I., Brain E-Tattoo Technology is Expected to Provide Continuous Monitoring for Uninterrupted Data Collection in Patients with Epilepsy, Alzheimer’s, Stroke, and More.

Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs™), today announced the appointment of W. Michael Flanagan, Ph.D. as Chief Technical Officer